We are live on ! Find out more
VXRT

Vaxart

Delisted

VXRT was delisted on the 7th of July, 2025.

38 hedge funds and large institutions have $18.3M invested in Vaxart in 2013 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 2

91% more capital invested

Capital invested by funds: $9.59M → $18.3M (+$8.7M)

86% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 7

15% more funds holding

Funds holding: 3338 (+5)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $209K

Holders
38
Holders Change
+5
Holders Change %
+15.15%
% of All Funds
1.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
13
Reduced
7
Closed
2
Calls
Puts
$209K
Net Calls
-$209K
Net Calls Change
+$135K

VXRT Hedge Fund Activity: Q3 2013 in Review

38 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q3 2013, worth a combined $18.3M — up 91% from $9.59M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new VXRT positions and 2 closed out — a net gain of 5 holders — while 13 added to existing stakes and 7 trimmed.

The largest buyer was BlackRock Advisors, adding an estimated $3.39M. The largest seller was Dimensional Fund Advisors, cutting an estimated $462K.

  • 38 institutional investors held Vaxart (VXRT) as of Q3 2013, up from 33 in Q2 2013.
  • Funds reported $18.3M of Vaxart stock for Q3 2013, up 91% quarter-over-quarter.
  • 7 funds opened new Vaxart positions in Q3 2013 and 2 closed out, a net change of +5 holders.
  • The largest Vaxart buyer in Q3 2013 was BlackRock Advisors, an estimated $3.39M added.
  • The largest Vaxart seller in Q3 2013 was Dimensional Fund Advisors, an estimated $462K sold.

Based on aggregated 13F filings for Q3 2013.